CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 114 enrolled
Drug / intervention
AZD3293 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02005211
NCT02005211Phase 1Completed
CompareCT.gov

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Effect on Biomarkers of AZD3293 in Healthy Japanese Male and Non-Fertile Female Volunteers Including Elderly

AstraZeneca·interventional·Posted Dec 9, 2013·Updated Nov 4, 2016

In Brief

A Phase 1 clinical trial evaluating AZD3293 and Placebo for Healthy Japanese Young and Elderly Male and Non-fertile Female Volunteers. Completed, enrolled 114 participants across 1 site.

Detailed Summary

This study consists of two parts, ie, single dose part with young healthy subjects (Part 1) and single and multiple dose part with elderly healthy subjects (Part 2), to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD3293 following single and multiple ascending dose administration to healthy subjects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Japanese Young and Elderly Male and Non-fertile Female Volunteers
CountriesJapan
Collaborators--

Timeline

Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 9, 2013
Enrollment StartDec 1, 2013
Primary CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 12.6 years ago

Interventions

AZD3293drug

Oral solution

Placebodrug

Oral solution